Metforminium Decavanadate as a Potential Metallopharmaceutical Drug for the Treatment of Diabetes Mellitus

Figure 4

Glycogen content in different tissues from groups to two months with treatments. (a–d) Independent insulin (I-I) model. (e–h) Insulin-requiring (I-R) model. The results shown are the average of 20 different experiments ± SEM. indicates significant difference above from the control group (NC); meanwhile ▼ indicates significant difference below from the control group (NC), both with group by ANOVA test with a Bonferroni post hoc test.